News
OmRx Oncology begins phase 2 trial of oral PD-L1 inhibitor OX-4224 in patients with non-small cell lung cancer: San Diego Saturday, May 10, 2025, 12:00 Hrs [IST] OmRx Oncology, or ...
Complete BriaCell Therapeutics Corp. Wt stock information by Barron's. View real-time BCTXZ stock price and news, along with industry-best analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback